More releases

• Jun 15, 2021
  Evonik boosts its system solutions portfolio with the acquisition of the cosmetic delivery company Infinitec Activos  
  Investor Relations
• Jun 10, 2021
  Evonik and Stanford University sign research collaboration: Evonik to market and develop new drug delivery platform for mRNA and gene therapy
  Investor Relations
• Jun 02, 2021
  Supervisory board extends contract with Christian Kullmann
  Investor Relations
• May 06, 2021
  Evonik more confident about full year after a strong first quarter
  Investor Relations
• Apr 22, 2021
  Start of production in record time: Evonik delivers first lipids from German facility to BioNTech today
  Investor Relations
• Apr 13, 2021
  Evonik “Division Spotlight Series”: Nutrition & Care set to unleash its full potential in new and more focused setup
  Investor Relations
• Mar 23, 2021
  Evonik aims to generate additional sales of at least €350 million by 2030 with solutions for circular plastics
  Investor Relations
• Mar 04, 2021
  Evonik gets through the pandemic well, is back on course for growth
  Investor Relations
• Feb 25, 2021
  Award for sustainability: Platinum rating for Evonik
  Investor Relations
• Feb 11, 2021
  Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine
  Investor Relations
• Dec 07, 2020
  Fight against COVID-19: Evonik supplies key technology for gene-based drugs
  Investor Relations
• Nov 12, 2020
  Evonik to complete the consolidation of its European production network for household care products this month
  Investor Relations
• Nov 03, 2020
  Evonik successfully completes acquisition of Porocel
  Investor Relations
• Nov 03, 2020
  Evonik is getting through the crisis well
  Investor Relations
• Oct 15, 2020
  Evonik delivers Q3 adjusted EBITDA of €519 million above market expectations
  Investor Relations
• Oct 13, 2020
  Evonik to concentrate MetAMINO® production at its three, world-scale, best-in-class hubs
  Investor Relations
• Sep 14, 2020
  Evonik launches its own GAA-product GuanAMINO®
  Investor Relations
• Aug 26, 2020
  Evonik acquires Porocel for US$210 million to accelerate growth of catalysts business
  Investor Relations
• Aug 04, 2020
  Evonik is getting through the crisis well
  Investor Relations
• May 11, 2020
  Evonik successfully places €500 million bond
  Investor Relations
• May 07, 2020
  Evonik makes a solid start to the year
  Investor Relations
• May 07, 2020
  Strategy Update: New structure and updated financial targets to push forward transformation
  Investor Relations
• Apr 06, 2020
  Evonik Industries AG postpones annual shareholders’ meeting 2020
  Investor Relations
• Mar 19, 2020
  Postponement Capital Markets Day 2020
  Investor Relations
• Mar 04, 2020
  Leading Beyond Chemistry
  Company
• Feb 03, 2020
  Evonik successfully closes acquisition of PeroxyChem
  Company
• Jan 13, 2020
  Press release of RAG-Stiftung: Successful placement of shares of Evonik Industries AG
  Investor Relations
• Nov 05, 2019
  Evonik confirms full-year earnings outlook despite ongoing weakness in global economy
  Investor Relations
• Oct 30, 2019
  Evonik and Dow develop industrial-scale direct synthesis of propylene glycol from propylene and hydrogen peroxide
  Investor Relations
• Aug 02, 2019
  Evonik acquisition of PeroxyChem delayed by FTC lawsuit
  Investor Relations
• Aug 01, 2019
  Evonik closes sale of Methacrylates business
  Investor Relations
• Aug 01, 2019
  Evonik sticks to full-year outlook despite cooling economy
  Investor Relations
• Jul 10, 2019
  Unique facility begins production of omega-3 fatty acids for sustainable salmon farming
  Investor Relations
• Jun 18, 2019
  Evonik commissions second complex for MetAMINO® production in Singapore
  Investor Relations
• May 07, 2019
  Evonik made a solid start to 2019
  Investor Relations
• Apr 11, 2019
  Evonik to support Chinese anti-dumping investigations for methionine
  Investor Relations
• Mar 05, 2019
  Change of strategy for pension assets to unburden Evonik's free cash flow
  Investor Relations
• Mar 04, 2019
  Evonik agrees to sell its Methacrylates business to Advent International for €3 billion
  Investor Relations
• Feb 13, 2019
  Evonik More Than Doubles Venture Capital to Accelerate Innovation
  Investor Relations
• Nov 30, 2018
  Evonik appoints new managers to its segments’ boards
  Investor Relations
• Nov 08, 2018
  Evonik acquires PeroxyChem for US$625 million
  Investor Relations
• Nov 07, 2018
  Evonik strengthens its activities in Precision Livestock Farming with acquisition of Belgian Big Data software provider Porphyrio
  Investor Relations
• Nov 06, 2018
  Good results in third quarter
  Investor Relations
• Nov 02, 2018
  Evonik invests in precision livestock start-up to improve poultry production
  Investor Relations